The Claim
In patients with established cardiovascular disease, targeting LDL cholesterol levels below 55 mg/dL leads to a significant reduction in major adverse cardiovascular events compared to less intensive LDL cholesterol targets.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
If you've already had heart problems, keeping your 'bad' cholesterol really low—below 55—might help prevent future heart attacks or strokes compared to aiming for a higher level.
See the scientific wording
Targeting LDL cholesterol below 55 mg/dL significantly reduces major adverse cardiovascular events compared to less intensive targets in patients with established cardiovascular disease.
What the research says
4 studiesStudy: Intensive LDL Cholesterol Targeting in Atherosclerotic Cardiovascular Disease
The study found that aiming for LDL cholesterol below 55 mg/dL led to fewer heart problems over 3 years compared to aiming for below 70 mg/dL in people who already had heart disease.
The study looked at whether stronger cholesterol treatment after a heart event helps prevent future problems. It found that lowering cholesterol more dramatically—especially in high-risk patients—leads to fewer heart attacks and strokes, which supports the idea that very low cholesterol targets are beneficial.
Study: Statins and the cholesterol mortality paradox
The study shows that lowering cholesterol very aggressively helps prevent heart attacks and strokes in people with heart disease, even if it doesn’t help them live longer overall.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 4 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.